Literature DB >> 9052782

An endothelial receptor for oxidized low-density lipoprotein.

T Sawamura1, N Kume, T Aoyama, H Moriwaki, H Hoshikawa, Y Aiba, T Tanaka, S Miwa, Y Katsura, T Kita, T Masaki.   

Abstract

Endothelial dysfunction or activation elicited by oxidatively modified low-density lipoprotein (Ox-LDL) has been implicated in the pathogenesis of atherosclerosis, characterized by intimal thickening and lipid deposition in the arteries. Ox-LDL and its lipid constituents impair endothelial production of nitric oxide, and induce the endothelial expression of leukocyte adhesion molecules and smooth-muscle growth factors, which may be involved in atherogenesis. Vascular endothelial cells in culture and in vivo internalize and degrade Ox-LDL through a putative receptor-mediated pathway that does not involve macrophage scavenger receptors. Here we report the molecular cloning, using expression cloning strategy, of an Ox-LDL receptor from vascular endothelial cells. The cloned receptor is a membrane protein that belongs structurally to the C-type lectin family, and is expressed in vivo in vascular endothelium and vascular-rich organs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9052782     DOI: 10.1038/386073a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  287 in total

1.  Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding.

Authors:  M Chen; S Narumiya; T Masaki; T Sawamura
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

Review 2.  The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review.

Authors:  R A Nixon; A M Cataldo; P M Mathews
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 3.  Platelet-endothelial interactions in atherosclerosis.

Authors:  B S Sachais
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

Review 4.  Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups.

Authors:  S M Moghimi; A C Hunter
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

5.  Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model.

Authors:  C L Welch; S Bretschger; N Latib; M Bezouevski; Y Guo; N Pleskac; C P Liang; C Barlow; H Dansky; J L Breslow; A R Tall
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 6.  New scavenger receptors and their functions in atherogenesis.

Authors:  Noriaki Kume; Toru Kita
Journal:  Curr Atheroscler Rep       Date:  2002-07       Impact factor: 5.113

7.  The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia.

Authors:  Mehmet Balin; Ahmet Celik; M Ali Kobat
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

Review 8.  Atherosclerosis in autoimmune diseases.

Authors:  Eiji Matsuura; Kazuko Kobayashi; Luis R Lopez
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

9.  Efficacy and Safety of Loading-Dose Rosuvastatin Therapy in Elderly Patients with Acute Coronary Syndromes Undergoing Elective Percutaneous Coronary Intervention.

Authors:  Yungen Jiao; Feng Hu; Zhengang Zhang; Kaizheng Gong; Xiaoning Sun; Aihua Li; Naifeng Liu
Journal:  Clin Drug Investig       Date:  2015-12       Impact factor: 2.859

10.  A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma.

Authors:  Fatima Solange Pasini; Bruno Zilberstein; Igor Snitcovsky; Rosimeire Aparecida Roela; Flavia R Rotea Mangone; Ulysses Ribeiro; Suely Nonogaki; Glauber Costa Brito; Giovanna D Callegari; Ivan Cecconello; Venancio Avancini Ferreira Alves; José Eluf-Neto; Roger Chammas; Miriam Hatsue Honda Federico
Journal:  J Gastroenterol       Date:  2013-11-12       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.